title: Early histopathologic changes in purple glove syndrome.
abstract: An 86-year-old African-American man presented with tonic-clonic seizures. Intravenous phenytoin was urgently administered into the dorsum of the right hand. The patient developed a raised purple area of discoloration around the intravenous insertion site within 2 h and edema and vesiculobullous lesions of the distal forearm, hands, and fingers within 8 h. Microscopic sections from a biopsy at 12 h revealed epidermal necrosis, superficial ulceration, and a mild superficial and deep perivascular lymphoid infiltrate, associated with numerous thrombi of small vessels throughout the dermis. The findings were judged to be consistent with soft-tissue injury associated with intravenous administration of phenytoin, also termed purple glove syndrome. Purple glove syndrome, named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands. It is comprised by pain, discoloration, and edema in the vicinity of intravenous infusion of phenytoin through dorsal veins of the hand. The histopathologic features of fully developed lesions have been reported; however, early-stage findings have not been previously described, and the histogenesis of this lesion is controversial. The presence of thrombi in this early-stage lesion suggests that thrombosis plays a role in the initial pathogenesis of this condition.
authors.affiliation: Departments of Pathology and Dermatology, Yale University School of Medicine, New Haven, CT 06520, USA.
authors.forename: Pradip
authors.initials: P
authors.lastname: Bhattacharjee
authors.forename: Earl J
authors.initials: EJ
authors.lastname: Glusac
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D006225:Hand / Q000473:pathology*; D006801:Humans; D007262:Infusions, Intravenous / Q000009:adverse effects*; D008297:Male; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects*; D012640:Seizures / Q000188:drug therapy; D017695:Soft Tissue Injuries / Q000209:etiology / Q000473:pathology*; D013927:Thrombosis / Q000473:pathology
chemical_list: D000927:Anticonvulsants; D010672:Phenytoin